SFM
GILD icon

Sphera Funds Management’s Gilead Sciences GILD Stock Holding History

Sphera Funds Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-120,000
Closed -$9.02M – 121
2013
Q4 		$9.02M Buy
+120,000
New +$8.36M 2.51% 9

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sphera Funds Management's GILD Position: Q1 2024 in Review

Sphera Funds Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 20,000 shares — an estimated $1.62M sold.

Sphera Funds Management first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $37.5M in Q2 2015. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Sphera Funds Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Sphera Funds Management sold 20,000 Gilead Sciences shares in Q1 2024, an estimated $1.62M.
  • Sphera Funds Management first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
  • Sphera Funds Management's Gilead Sciences position peaked at $37.5M in Q2 2015.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.